2 results
Approved WMORecruiting
The study the safety and imaging characteristics of GE-137
Approved WMORecruiting
To determine a safe dose combination of carboplatin-cyclophosphamide combined with atezolizumab fixed dose in advanced breast cancer and gynaecologic cancer (ovarian, cervical and endometrial cancer).